These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
409 related items for PubMed ID: 26831345
1. [The place of inhaled corticosteroids in COPD]. Chinet T, Dumoulin J, Honore I, Braun JM, Couderc LJ, Febvre M, Mangiapan G, Maurer C, Serrier P, Soyez F, Terrioux P, Jebrak G. Rev Mal Respir; 2016 Dec; 33(10):877-891. PubMed ID: 26831345 [Abstract] [Full Text] [Related]
2. Inhaled corticosteroids for stable chronic obstructive pulmonary disease. Yang IA, Fong KM, Sim EH, Black PN, Lasserson TJ. Cochrane Database Syst Rev; 2007 Apr 18; (2):CD002991. PubMed ID: 17443520 [Abstract] [Full Text] [Related]
3. [The effects of inhaled steroids withdrawal in COPD]. Jebrak G, Honore I, Serrier P, Dumoulin J, Terrioux P, Soyez F, Maurer C, Mangiapan G, Febvre M, Couderc LJ, Braun JM, Chinet T. Rev Mal Respir; 2017 Oct 18; 34(8):820-833. PubMed ID: 28506728 [Abstract] [Full Text] [Related]
4. "Real-life" inhaled corticosteroid withdrawal in COPD: a subgroup analysis of DACCORD. Vogelmeier C, Worth H, Buhl R, Criée CP, Lossi NS, Mailänder C, Kardos P. Int J Chron Obstruct Pulmon Dis; 2017 Oct 18; 12():487-494. PubMed ID: 28203072 [Abstract] [Full Text] [Related]
5. Effect of outpatient therapy with inhaled corticosteroids on decreasing in-hospital mortality from pneumonia in patients with COPD. Yamauchi Y, Yasunaga H, Hasegawa W, Sakamoto Y, Takeshima H, Jo T, Matsui H, Fushimi K, Nagase T. Int J Chron Obstruct Pulmon Dis; 2016 Oct 18; 11():1403-11. PubMed ID: 27382276 [Abstract] [Full Text] [Related]
6. A proposal for the withdrawal of inhaled corticosteroids in the clinical practice of chronic obstructive pulmonary disease. Miravitlles M, Cosío BG, Arnedillo A, Calle M, Alcázar-Navarrete B, González C, Esteban C, Trigueros JA, Rodríguez González-Moro JM, Quintano Jiménez JA, Baloira A. Respir Res; 2017 Nov 28; 18(1):198. PubMed ID: 29183382 [Abstract] [Full Text] [Related]
7. The place of inhaled corticosteroids in the treatment of chronic obstructive pulmonary disease: a narrative review. Andreeva-Gateva PA, Stamenova E, Gatev T. Postgrad Med; 2016 Jun 28; 128(5):474-84. PubMed ID: 27153510 [Abstract] [Full Text] [Related]
8. Inappropriate inhaled corticosteroid prescribing in chronic obstructive pulmonary disease patients. Harrison A, Borg B, Thompson B, Hew M, Dabscheck E. Intern Med J; 2017 Nov 28; 47(11):1310-1313. PubMed ID: 29105270 [Abstract] [Full Text] [Related]
9. Assessing the healthcare resource use associated with inappropriate prescribing of inhaled corticosteroids for people with chronic obstructive pulmonary disease (COPD) in GOLD groups A or B: an observational study using the Clinical Practice Research Datalink (CPRD). Chalmers JD, Poole C, Webster S, Tebboth A, Dickinson S, Gayle A. Respir Res; 2018 Apr 11; 19(1):63. PubMed ID: 29642882 [Abstract] [Full Text] [Related]
10. The Pharmacological Treatment of Chronic Obstructive Pulmonary Disease. Gillissen A, Haidl P, Khlhäufl M, Kroegel K, Voshaar T, Gessner C. Dtsch Arztebl Int; 2016 May 06; 113(18):311-6. PubMed ID: 27215595 [Abstract] [Full Text] [Related]
11. LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes. Hizawa N. Int J Chron Obstruct Pulmon Dis; 2015 May 06; 10():1093-102. PubMed ID: 26089659 [Abstract] [Full Text] [Related]
12. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis. Baker WL, Baker EL, Coleman CI. Pharmacotherapy; 2009 Aug 06; 29(8):891-905. PubMed ID: 19637942 [Abstract] [Full Text] [Related]
13. Withdrawal of inhaled corticosteroids versus continuation of triple therapy in patients with COPD in real life: observational comparative effectiveness study. Magnussen H, Lucas S, Lapperre T, Quint JK, Dandurand RJ, Roche N, Papi A, Price D, Miravitlles M, Respiratory Effectiveness Group (REG). Respir Res; 2021 Jan 21; 22(1):25. PubMed ID: 33478491 [Abstract] [Full Text] [Related]
14. Risk-to-benefit ratio of inhaled corticosteroids in patients with COPD. Price D, Yawn B, Brusselle G, Rossi A. Prim Care Respir J; 2013 Mar 21; 22(1):92-100. PubMed ID: 23135217 [Abstract] [Full Text] [Related]
15. Inhaled corticosteroids for chronic obstructive pulmonary disease. Cazzola M, Rogliani P, Novelli L, Matera MG. Expert Opin Pharmacother; 2013 Dec 21; 14(18):2489-99. PubMed ID: 24138334 [Abstract] [Full Text] [Related]
16. Inhaled corticosteroids can reduce osteoporosis in female patients with COPD. Liu SF, Kuo HC, Liu GH, Ho SC, Chang HC, Huang HT, Chen YM, Huang KT, Chen KY, Fang WF, Lin MC. Int J Chron Obstruct Pulmon Dis; 2016 Dec 21; 11():1607-14. PubMed ID: 27478374 [Abstract] [Full Text] [Related]
17. [Secondary osteoporosis: Inhaled corticosteroids induced osteoporosis in respiratory diseases]. Ieda Y, Nagasaka Y. Clin Calcium; 2007 Jun 21; 17(6):955-62. PubMed ID: 17548937 [Abstract] [Full Text] [Related]
18. Inhaled Corticosteroids for Chronic Obstructive Pulmonary Disease--The Shifting Treatment Paradigm. Wilkie M, Finch S, Schembri S. COPD; 2015 Jun 21; 12(5):582-90. PubMed ID: 25774769 [Abstract] [Full Text] [Related]
19. Benefits and risks of inhaled corticosteroids in chronic obstructive pulmonary disease. Bonay M, Bancal C, Crestani B. Drug Saf; 2002 Jun 21; 25(1):57-71. PubMed ID: 11820912 [Abstract] [Full Text] [Related]
20. Blood eosinophil count and pneumonia risk in patients with chronic obstructive pulmonary disease: a patient-level meta-analysis. Pavord ID, Lettis S, Anzueto A, Barnes N. Lancet Respir Med; 2016 Sep 21; 4(9):731-741. PubMed ID: 27460163 [Abstract] [Full Text] [Related] Page: [Next] [New Search]